Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. - Wikidata - wikimedia - TriplyDB

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.

http://www.wikidata.org/entity/Q40335203

about

N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer Application of glycoscience to the early detection of pancreatic cancer Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Pancreatic cancer serum detection using a lectin/glyco-antibody array method Antigen identification and characterization of lung cancer specific monoclonal antibodies produced by mAb proteomics.Fucosylation is a promising target for cancer diagnosis and therapy Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies Proteomics in pancreatic cancer research.N-linked glycan changes of serum haptoglobin β chain in liver disease patients.Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER.Glycoproteomic analysis and molecular modeling of haptoglobin multimers.Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer.Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin.Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells Fucosylation in prokaryotes and eukaryotes.Biological function of fucosylation in cancer biology.Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.Overexpression of α1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner.The identification and characterization of novel N-glycan-based biomarkers in gastric cancer.Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.Direct site-specific glycoform identification and quantitative comparison of glycoprotein therapeutics: imiglucerase and velaglucerase alfa Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.Glycosylation status of serum immunoglobulin G in patients with prostate diseases.Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics.Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases.Analytical glycobiology at high sensitivity: current approaches and directions Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma

P2860

Q21245732-308BAC39-33F0-4805-9CDA-11D7B8EE2B9B Q26748089-7D933687-065E-4B23-9D69-0BE6930F8572 Q28066814-EE7BFFBD-516A-4B64-8B9A-8F70C2606AD8 Q30576595-DABBA766-536F-49E3-948D-FCD5C1A66AA4 Q33391974-EF31D449-2DCF-49B5-9ED1-52D9B4348E20 Q33530521-839B10BD-10A9-4117-8B2F-566F7A686050 Q33649601-ED3AC50E-50BA-460B-84D1-D5B9A478EC58 Q33762901-ADB0328B-3E54-437A-8835-099D3F7F27FF Q33791981-0E604857-C4B8-4230-8A73-2084373ECCEC Q33838472-7BC6C0E0-E9DC-45D2-994C-F1140CEBC157 Q33850105-9CEDEB0D-DB92-47A1-81B1-A846207CCF9B Q33888457-887EEB3C-3282-405C-9B03-27CB98F2C193 Q33893239-7FA6C57D-2DB9-4E35-B435-B465B41D4D3D Q33938305-C09B61DA-A528-4955-A046-A16238D337BE Q34030497-E907CE25-59C0-47CD-B0AF-471DF761364E Q34094822-F3B8DA19-919E-423B-8E3A-2D2D5E4305A4 Q34161256-03310526-F08F-4EAE-9C42-8F3F35A53D5C Q34292392-7F0EE48D-82B0-42CF-8085-29C31153F70D Q34566205-9D468BBA-A802-47F6-BF43-8AEBB0DA6AAC Q34740910-85336BDD-7DB0-47A7-B340-E96EFE0FD0C7 Q34785324-669631CE-C539-483B-B062-D971C720B97E Q34984675-2919682F-69E7-420F-A0E2-888B5BC7F577 Q35023434-9CB3362A-493A-4BE1-8937-E85A6163EE43 Q35104034-ED4E5F53-45E7-43F1-8EA1-5CEC423A1C31 Q35148539-3F867892-3B8F-4A6F-9C09-AF56836A6838 Q35192876-752F19D7-16B2-488A-A46D-1620D0092354 Q35502067-D45488C9-5ED8-45F9-84D3-BBB3CB6FAEBD Q35647524-DA9CF054-5E91-4603-B3B0-7AAE185C90A4 Q35768232-A8D39265-5FBA-44EA-9183-B943DCF9F38B Q35794259-E2A82734-5B1D-4C91-8D70-4DFAC31DF125 Q35874854-535EC403-DFDD-4377-9BD8-6F2474C46668 Q35924714-2DA2F99C-2160-49DA-A80E-A9A0A9ECC7E1 Q35965881-895C4561-D5CA-4D2A-9846-54BE359E1EFC Q36088189-9DD2015C-5804-4F84-AC0A-3BFBF3953C79 Q36089872-50D9CBEA-0C4F-4800-AAAD-CF47908957A5 Q36270131-2EE8C20F-B8D0-4C4F-BF11-57B0EFA70CED Q36369527-62803932-756F-4A5D-AB43-69137830D553 Q36452789-CE934C53-C550-49F0-9F35-349ACFF6A718 Q36651493-69F5F2A3-44AC-4935-A7BC-0560DDF04687 Q36832489-A6235B1E-239B-486D-BA91-E574F4207D40

P2860

Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.

http://www.wikidata.org/entity/Q40335203

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Fucosylated haptoglobin is a n ...... le mechanism for fucosylation.

@en

type

label

Fucosylated haptoglobin is a n ...... le mechanism for fucosylation.

@en

prefLabel

Fucosylated haptoglobin is a n ...... le mechanism for fucosylation.

@en

P1433

Q40335203-50CD8A22-21B3-44F9-9FD5-BFD2AA7220F6

P1476

Q40335203-ACE1A7EB-1737-49FC-B49A-84AA4F22FE72

P2093

Q40335203-036244C3-69D9-49A3-967F-1EFB727DA6DC

Q40335203-31F5F82D-B219-4283-8393-B1F9CE7DBAA1

Q40335203-34EC2AE8-FC99-4612-B7E4-8724F5BC6D76

Q40335203-375CC897-3767-4990-8F2B-72987BDB03BD

Q40335203-4A63D146-AC51-4DDB-BBE7-CDF1D845B237

Q40335203-60C01325-64DB-42E6-AC28-883679BC9D52

Q40335203-6173A89C-CE4C-4708-AF9D-32FA97223592

Q40335203-6B515D90-50F8-40E2-A4D1-C67127BA4DF2

Q40335203-7B0877A8-B766-4CE6-AB52-60EF98F35F0A

Q40335203-7E2F5C13-5928-4FEE-B68F-4771916018E3

P2860

Q40335203-C3F0D1B5-0790-4245-9C4B-FFE153FB8904

P304

Q40335203-32CDA252-8ACC-4403-989F-D0472A5DDDF2

P31

Q40335203-A5803FA5-4F9E-48BB-97E0-2051F1E53208

P356

Q40335203-F4046387-AC50-45FC-A6A1-FCCAA799435C

P433

Q40335203-D266F87D-0630-432A-BECB-0CBAB7EB8249

P478

Q40335203-7D6192EA-63AF-43EE-B9F4-EED3576F2B91

P577

Q40335203-C3B5CDAB-23AD-45FF-9A8F-56A354CD5595

P5875

Q40335203-4ECF6061-D1CF-4B84-A74E-4ED82903A816

P698

Q40335203-4AD7C001-25EA-45A9-A64A-986606E9497A

P921

Q40335203-DF7FE464-74E8-4D09-849F-C6751B1018B5

P356

P1433

International Journal of Cancer

P1476

Fucosylated haptoglobin is a n ...... le mechanism for fucosylation.

@en

P2093

Akinori Kasahara

http://www.w3.org/2001/XMLSchema#string

Eiji Miyoshi

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Eguchi

http://www.w3.org/2001/XMLSchema#string

Hiroaki Ohigashi

http://www.w3.org/2001/XMLSchema#string

Jianguo Gu

http://www.w3.org/2001/XMLSchema#string

Kanako Yamanaka

http://www.w3.org/2001/XMLSchema#string

Kenta Moriwaki

http://www.w3.org/2001/XMLSchema#string

Kohei Murata

http://www.w3.org/2001/XMLSchema#string

Michio Kato

http://www.w3.org/2001/XMLSchema#string

Miyako Nakano

http://www.w3.org/2001/XMLSchema#string

P2860

Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.

P304

2803-2808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.21728

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7384896

http://www.w3.org/2001/XMLSchema#string

P698

16385567

http://www.w3.org/2001/XMLSchema#string

P921

oligosaccharide